COVID-19 Collection

Journal article

Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial

Abstract:: Importance: The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain.

Objective: To determine whether antiplatelet therapy improves outcomes for critically ill adults with COVID-19.

Design, Setting, and Participants: In an ongoing adaptive platform trial (REMAP-CAP) testing multiple interventions within multiple therapeutic domains, 1557 critically ill adult patients with COVID-19 were ...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Bradbury, C., Lawler, P., Stanworth, S., McVerry, B., McQuilten, Z., Higgins, A., Mouncey, P., Al-Beidh, F., Rowan, K., Berry, L., Lorenzi, E., Zarychanski, R., Arabi, Y., Annane, D., Beane, A., van Bentum-Puijk, W., Bhimani, Z., Bihari, S., Bonten, M., … Murthy, S. (2022). Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial. JAMA, 327(13), 1247–1259.

MLA Style

Bradbury, CA, et al. “Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients with COVID-19: A Randomized Clinical Trial.” JAMA, vol. 327, no. 13, 2022, pp. 1247–59.

Chicago Style

Bradbury, CA, PR Lawler, SJ Stanworth, et al. 2022. “Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients with COVID-19: A Randomized Clinical Trial.” JAMA 327 (13): 1247–59.
Print

Access Document

Publisher copy:: 10.1001/jama.2022.2910

Authors

+ Bradbury, CA More by this author

Role:: Author

+ Lawler, PR More by this author

Role:: Author

+ Stanworth, SJ More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Oxford college:: Wadham College
Role:: Author
ORCID:: 0000-0002-7414-4950

+ McVerry, BJ More by this author

Role:: Author

+ McQuilten, Z More by this author

Role:: Author

More authors...

Contributors

+ REMAP-CAP Writing Committee for the REMAP-CAP Investigators

Role:: Contributor

Publisher:: American Medical Association
Journal:: JAMA More from this journal
Volume:: 327
Issue:: 13
Pages:: 1247-1259
Publication date:: 2022-03-22
Acceptance date:: 2022-02-14
DOI:: 10.1001/jama.2022.2910
EISSN:: 1538-3598
ISSN:: 0098-7484
Pmid:: 35315874

Language:: English
Keywords:: REMAP-CAP Writing Committee for the REMAP-CAP Investigators

FFR
Pubs id:: 1248174
Local pid:: pubs:1248174
Deposit date:: 2022-06-17
ARK identifier:: ark:/29072/ora_b8080f8a993d48449f861f101a4d9360

Terms of use

Copyright holder:: American Medical Association
Copyright date:: 2022
Rights statement:: © 2022 American Medical Association. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP